MARKET

TCBP

TCBP

TC BioPharm (Holdings) Ltd
NASDAQ
1.540
-0.010
-0.65%
After Hours: 1.550 +0.01 +0.66% 19:02 03/29 EDT
OPEN
1.550
PREV CLOSE
1.550
HIGH
1.648
LOW
1.520
VOLUME
67.01K
TURNOVER
0
52 WEEK HIGH
106.50
52 WEEK LOW
1.460
MARKET CAP
1.22M
P/E (TTM)
-0.0684
1D
5D
1M
3M
1Y
5Y
BRIEF-TC BioPharm Announces Pricing Of $5.5 Mln Public Offering
Reuters · 1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 1d ago
TC BioPharm prices ~$5.5M public offering
Seeking Alpha · 1d ago
iHeartMedia, Invesco Mortgage Capital, FiscalNote among premarket losers' pack
Seeking Alpha · 1d ago
TC BioPharm Prices $5.5 Million Securities Offering
TC BioPharm Prices $5.5 Million Securities Offering
MT Newswires · 1d ago
Dermata, GH Research top healthcare gainers; BridgeBio, Cidara among losers
Seeking Alpha · 5d ago
Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 5d ago
Possibility of US Fed's Rate Hike Pause Supports American Depositary Receipts of European Equities
Possibility of US Fed's Rate Hike Pause Supports American Depositary Receipts of European Equities
MT Newswires · 6d ago
More
About TCBP
TC BioPharm Limited is a clinical-stage biopharmaceutical company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma-delta T cell therapies for the treatment of infectious disease. The Company's platform technology allows Company to design specific therapies to treat a range of cancers and infectious diseases with off-the-shelf allogeneic gamma-delta T cell (GDT) products. The Company’s pipeline includes OmnImmune, ImmuniStim and CAR-T programs. OmnImmune is an unmodified allogeneic gamma-delta T cell product, being used for the treatment of acute myeloid leukemia (AML). ImmuniStim is an unmodified allogeneic gamma-delta T cell product, being used for the treatment of COVID-19. The Company also provides in-house and partner programs at the pre-clinical stage focused on developing CAR-modified allogeneic gamma delta T-cell products targeting solid and hematological indications.

Webull offers kinds of TC BioPharm Ltd (ADR) stock information, including NASDAQ:TCBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCBP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TCBP stock methods without spending real money on the virtual paper trading platform.